Anhui Huaheng Biotechnology Co., Ltd. (688639.SH): Net profit for 2024 is 200 million yuan, a decrease of 55.51% year-on-year.
Huaheng Biology (688639.SH) released its 2024 annual performance report announcement, during the reporting period, the company achieved operating revenue.
Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) released its 2024 annual performance report, reporting a total operating income of 2.184 billion yuan, a year-on-year increase of 12.70%; a net profit attributable to the shareholders of the listed company of 200 million yuan, a year-on-year decrease of 55.51%; a net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses of 186 million yuan, a year-on-year decrease of 57.56%; and a basic earnings per share of 0.86 yuan/share.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


